Testicular cancer is the most common solid tumor among young men aged 15 to 35 years. Combination chemotherapy with cisplatin, etoposide, and bleomycin remains the mainstay of treatment. We present a 27-year-old man who presented with an acute anterior myocardial infarction during the second course of chemotherapy for seminoma. Because the patient had no significant risk factors for coronary heart disease, the infarction was likely caused by the chemotherapy regimen.
Chaudhary UB , Haldas JRLong-term complications of chemotherapy for germ cell tumours. Drugs. 2003;63: 1565-1577.
2.
Nichols CR, Roth BJ, Williams SD, et al. No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study . J Clin Oncol.1992;10:760-765.
3.
Mermershtain W., Dudnik J., Gusakova I., et al. Acute myocardial infarction in a young man receiving chemotherapy for testicular cancer: case report. J Chemother.2001; 13:658-660.
4.
Bachmeyer C. , Joly H., Jorest R.Early myocardial infarction during chemotherapy for testicular cancer. Tumori.2000;86:428-430.
5.
Icli F., Karaoguz H., Dincol D., et al. Severe vascular toxicity associated with cisplatin-based chemotherapy . Cancer. 1993;72:587-593.
6.
Borek G., Gebel F., Jenzer HRAcute myocardial infarct following chemotherapy for testicular carcinoma: on the coronary toxicity of cytostatic agents. Schweiz Med Wochenschr.1991;121:385-389.
7.
Hannun Y., Vugrin D.Long-term survival in patients treated for testicular seminoma. J Surg Oncol.1990;43: 177-180.
8.
Vos AH, Splinter TA, van der Heul C.Arterial occlusive events during chemotherapy for germ cell cancer. Neth J Med.2001;59:295-299.
9.
Doll DC, List AF, Greco FA, et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med.1986; 105:48-51.
10.
Sallah S., Wan JY, Nguyen NPVenous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost.2002;87:575-579.
11.
Lin J., Proctor MC, Varma M., Greenfield LJ, Upchurch GR Jr, Henke PKFactors associated with recurrent venous thromboembolism in patients with malignant disease. J Vasc Surg.2003;37:976-983.
12.
Harrington KJ, Bateman AR, Syrigos KN, et al. Cancer-related thromboembolic disease in patients with solid tumours: a retrospective analysis. Ann Oncol.1997;8: 669-673.
13.
Berliner S. , Rahima M., Sidi Y., et al. Acute coronary events following cisplatin-based chemotherapy. Cancer Invest.1990;8:583-586.
